Power Law company profile

Nautilus

Biotech & Life Sciences · San Carlos, United States · Founded 2016 Unicorn

Delivering a high-throughput, low-cost platform for analyzing and quantifying the human proteome

Valuation

$268M

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on Nautilus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 8 investors entered at this stage

Madrona Venture Group

Bolt Ventures

Defy Partners

Global footprint

Where Nautilus has talent and traffic

AI talent share

2.1% of workforce is AI talent
(3 of 143 staff)

Core AI32.1%

Other AI00%

Non-AI workforce14097.9%

Workforce by country

3 countries with
team presence

🇺🇸 United States98.2%

🇬🇧 United Kingdom0.9%

🇮🇳 India0.9%

3 countries shown

Web traffic by country

19K monthly visits
across markets

🇺🇸 United States62.1%

🇬🇧 United Kingdom12.1%

🇮🇳 India10.5%

🇨🇦 Canada6.8%

🇭🇰 Hong Kong3.2%

Top 5 markets shown

Market sentiment

What the market is saying about Nautilus

An AI-synthesized read of the highest-engagement posts about Nautilus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nautilus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles